| Ms Jennifer L Bartelo, OTR/L | |
|
2495 Main St, Suite 234, Buffalo, NY 14214-2152 | |
| (716) 836-5929 | |
| Not Available |
| Full Name | Ms Jennifer L Bartelo |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2495 Main St, Buffalo, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063717445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Buffalo Rehab Group Physical Therapy And Occupational Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1548290943 PECOS PAC ID: 1355232596 Enrollment ID: O20040324001331 |
News Archive
Isis Pharmaceuticals, Inc. today provided an update on children with spinal muscular atrophy (SMA) who have completed the open-label, Phase 2 multiple-dose study of ISIS-SMN Rx and are continuing to receive treatment in an open-label extension (OLE) study.
Portico Systems, the leader in Integrated Provider Management solutions, was chosen by IDC Health Insights to be the focus for a special report that provides a detailed view into Portico's market position, provider management software and service capabilities and future strategic direction. Additionally, the report provides analyst commentary on why assets such as Portico are necessary for successful reform change.
A new study shows there is a gender gap when it comes to behavior and self-control in American young children - one that does not appear to exist in children in Asia.
Milestone Scientific Inc., the recognized leader in advanced injection technologies, today issued a formal corporate update relating to the Company's new business opportunities in China. Specifically, Milestone is currently working in concert with its Chinese distribution partner, China National Medicines Corporation to advance the STA System™ through the required regulatory review and approval process at the State Food and Drug Administration for the People's Republic of China.
Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer L Bartelo, OTR/L 205 Euclid Ave, Hamburg, NY 14075-3806 Ph: (716) 816-9819 | Ms Jennifer L Bartelo, OTR/L 2495 Main St, Suite 234, Buffalo, NY 14214-2152 Ph: (716) 836-5929 |
News Archive
Isis Pharmaceuticals, Inc. today provided an update on children with spinal muscular atrophy (SMA) who have completed the open-label, Phase 2 multiple-dose study of ISIS-SMN Rx and are continuing to receive treatment in an open-label extension (OLE) study.
Portico Systems, the leader in Integrated Provider Management solutions, was chosen by IDC Health Insights to be the focus for a special report that provides a detailed view into Portico's market position, provider management software and service capabilities and future strategic direction. Additionally, the report provides analyst commentary on why assets such as Portico are necessary for successful reform change.
A new study shows there is a gender gap when it comes to behavior and self-control in American young children - one that does not appear to exist in children in Asia.
Milestone Scientific Inc., the recognized leader in advanced injection technologies, today issued a formal corporate update relating to the Company's new business opportunities in China. Specifically, Milestone is currently working in concert with its Chinese distribution partner, China National Medicines Corporation to advance the STA System™ through the required regulatory review and approval process at the State Food and Drug Administration for the People's Republic of China.
Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.
› Verified 5 days ago
Laura L Lechner, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Community Dr, Buffalo, NY 14225 Phone: 716-505-5630 Fax: 716-892-1936 | |
Mrs. Bethany B Hauer, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Buffalo Hearing And Speech, 50 East North St, Buffalo, NY 14203 Phone: 716-885-8318 Fax: 716-885-0229 | |
Mrs. Deborah Ann Fitzgerald, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 | |
Cheryl Kagen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 | |
Ms. Andrea Cudney, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 301 Connecticut St Ste 202, Buffalo, NY 14213 Phone: 716-923-4617 | |
Miss Lisa Anne Dagustine, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Buffalo, NY 14214 Phone: 716-836-5929 | |
Michelle Moulin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Main St, Suite 234, Buffalo, NY 14214 Phone: 716-836-5929 |